<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
  <channel>
    <title>Scopus Biopharma Inc — News on 6ix</title>
    <link>https://6ix.com/company/scopus-biopharma-inc</link>
    <description>Latest news and press releases for Scopus Biopharma Inc on 6ix.</description>
    <language>en-us</language>
    <lastBuildDate>Tue, 07 Nov 2023 14:15:30 GMT</lastBuildDate>
    <generator>6ix RSS</generator>
    <atom:link href="https://6ix.com/rss/company/scopus-biopharma-inc" rel="self" type="application/rss+xml" />
    <image>
      <url>https://6ix-events-pro.s3.amazonaws.com/6ixvideo/logos/org-logo6835bdce78dffbe2df1175d0.webp</url>
      <title>Scopus Biopharma Inc</title>
      <link>https://6ix.com/company/scopus-biopharma-inc</link>
    </image>
    <item>
      <title>Scopus BioPharma’s Subsidiary — Duet BioTherapeutics — Presents Compelling New Data for a Novel Treatment for Malignant Glioma at 38th Annual Meeting of the Society for Immunotherapy of Cancer</title>
      <link>https://6ix.com/company/scopus-biopharma-inc/news/scopus-biopharmas-subsidiary-duet-biotherapeutics-presents-compelling-new-data-for-a-novel-treatment-for-malignant-glioma-at-38th-annual-meeting-of-the-society-for-immunotherapy-of-cancer</link>
      <guid isPermaLink="true">https://6ix.com/company/scopus-biopharma-inc/news/scopus-biopharmas-subsidiary-duet-biotherapeutics-presents-compelling-new-data-for-a-novel-treatment-for-malignant-glioma-at-38th-annual-meeting-of-the-society-for-immunotherapy-of-cancer</guid>
      <pubDate>Tue, 07 Nov 2023 14:15:30 GMT</pubDate>
      <description>Scopus BioPharma’s Subsidiary — Duet BioTherapeutics — Presents Compelling New Data for a Novel Treatment for Malignant Glioma at 38th Annual Meeting of the Society for Immunotherapy of Cancer.</description>
    </item>
    <item>
      <title>Scopus BioPharma’s Subsidiary — Duet BioTherapeutics — to Present at the 38th Annual Meeting of the Society for Immunotherapy of Cancer</title>
      <link>https://6ix.com/company/scopus-biopharma-inc/news/scopus-biopharmas-subsidiary-duet-biotherapeutics-to-present-at-the-38th-annual-meeting-of-the-society-for-immunotherapy-of-cancer</link>
      <guid isPermaLink="true">https://6ix.com/company/scopus-biopharma-inc/news/scopus-biopharmas-subsidiary-duet-biotherapeutics-to-present-at-the-38th-annual-meeting-of-the-society-for-immunotherapy-of-cancer</guid>
      <pubDate>Thu, 02 Nov 2023 13:15:12 GMT</pubDate>
      <description>Scopus BioPharma’s Subsidiary — Duet BioTherapeutics — to Present at the 38th Annual Meeting of the Society for Immunotherapy of Cancer.</description>
    </item>
    <item>
      <title>OTC Markets Group Welcomes New OTCQB Companies – December 27</title>
      <link>https://6ix.com/company/scopus-biopharma-inc/news/otc-markets-group-welcomes-new-otcqb-companies-december-27</link>
      <guid isPermaLink="true">https://6ix.com/company/scopus-biopharma-inc/news/otc-markets-group-welcomes-new-otcqb-companies-december-27</guid>
      <pubDate>Tue, 27 Dec 2022 12:00:00 GMT</pubDate>
      <description>OTC Markets Group Welcomes New OTCQB Companies – December 27.</description>
    </item>
  </channel>
</rss>